Lung Academy webinar: Focus on difficult to treat patients with advanced NSCLC (16.00 – 17.15 CEST.)

Lung Academy_300x179

September 28th 16.00 – 17.15 CEST (Click HERE to register for September 28th 20.00 – 21.15 CEST)

Join us in our live interactive expert meeting where our experts will focus on the difficult to treat patients with advanced NSCLC, with a particular focus on patients with a squamous histology, locally advanced disease (Stage III) patients, and patients with brain metastases.

This webinar will be held on two occasions; in the afternoon and evening. Both webinars will cover the same topics and will be live events.
Register on this page for the afternoon session, or click here to register for the evening session.

Agenda

  • 16.00 - 16.20 NSCLC with a squamous histology
  • 16.20 - 16.40 Locally advanced (Stage III) NSCLC patients
  • 16.40 - 17.00 Brain metastases in NSCLC
  • 17.00 - 17.15 Q&A

Date

These webinars will broadcast on:

  • Wednesday 28th of September 2022 from 16.00 – 17.15 CEST.
  • Wednesday 28th of September 2022 from 20.00 – 21.15 CEST. Click HERE tot register for this time.

Easy registration

Create an account or log in with your existing account on this website.

Audience

This webinar is primarily intended for oncologists and pulmonologists.

Accreditation

Accreditation is requested from NVALT in the Netherlands and for pulmonologists and oncologists in Belgium.

Free webinar

Participation in this webinar is free of charge.

Questions?

If you have any questions, please send an email to nascholing@springer.com.

 

This is a non promotional event sponsored by:

MAT-BE-2200453.V1.0 – July 2022

In the context of GDPR, Springer complies with the laws and regulations as laid down by this law. For this webinar it applies that it concerns a collaboration between Springer and Sanofi and that they each determine their own purpose and means in the processing of personal data. Springer and Sanofi are therefore separately responsible for processing. The privacy conditions that apply can be found here: Springer Healthcare & Sanofi.

Denmark

Arrangementet er/vil blive anmeldt til ENLI, inden arrangementets afholdelse. Arrangementet er efter arrangørernes opfattelse i overensstemmelse med reglerne på området, selv om arrangementet ikke på forhånd er godkendt af ENLI.

Norway

Dette arrangementet arrangeres i samsvar med avtaler om samhandling som Legemiddelindustri-foreningen har inngått med Den norske legeforening, Norges Farmaceutiske Forening, Norsk Sykepleierforbund og De regionale helseforetakene. For mer informasjon se https://www.lmi.no/lmi/fagomrader/lover-og-regler/samarbeidsavtaler/. Deltaker ansatt i helseforetak er selv ansvarlig for å innhente tillatelse fra arbeidsgiver for å delta på møtet. Vårt firma ønsker å bidra til at de regler og prosedyrer for egenbetaling som gjelder for helseforetaket blir fulgt. Sanofi behandler personopplysninger i henhold til GDPR.

Sweden

Inbjudan skickas till sjukvårdspersonal inom berört område.
Mötet är kostnadsfritt och följer de regler som gäller enligt avtalet mellan LIF och Sveriges Kommuner och Regioner. Vi ber dig notera att huvudmans godkännande ska inhämtas före deltagande i mötet. Sanofi står för arvode till föreläsarna.

 

 

To continue reading, please log in

Log in with your BSL Account

Log in

Forgot your password?

No BSL Account yet? Please register

Register

More information on BSL Accounts.